In Heart attack prevention and high cholesterol Lipikind CV 20 Capsule is a combination medicine that is used to prevent heart attack. It contains Atorvastatin that works by reducing the amount of “bad” cholesterol (LDL) and raising the amount of “good” cholesterol (HDL) in your blood. High levels of cholesterol can cause your blood vessels to narrow (atherosclerosis). Lowering the amount of cholesterol reduces the chances of heart diseases and helps you remain healthier for longer. Besides, it also contains a blood thinner, Clopidogrel, that prevents the formation of blood clots and also prevents the existing ones from growing bigger in size. Take it regularly and make appropriate lifestyle changes (such as eating healthy and staying active) to maximize the effectiveness of this medicine. Keep taking it even if you feel well.
It is unsafe to consume alcohol with Lipikind CV 20 Capsule.
Lipikind CV 20 Capsule is highly unsafe to use during pregnancy. Seek your doctor's advice as studies on pregnant women and animals have shown significant harmful effects to the developing baby.
Lipikind CV 20 Capsule is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
Lipikind CV 20 Capsule does not usually affect your ability to drive.
There is limited information available on the use of Lipikind CV 20 Capsule in patients with kidney disease. Please consult your doctor.
Lipikind CV 20 Capsule should be used with caution in patients with liver disease. Dose adjustment of Lipikind CV 20 Capsule may be needed. Please consult your doctor. Use of Lipikind CV 20 Capsule is not recommended in patients with severe liver disease and active liver disease.
If you miss a dose of Lipikind CV 20 Capsule, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More
Marketer/Manufacturer: Docheal Pharma Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Sun Pharmaceutical Industries Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Ajanta Pharma Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Micro Labs Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Macleods Pharmaceuticals Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Jubilant Life Sciences || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Sun Pharmaceutical Industries Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Dr Reddy's Laboratories Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Cipla Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)